|
|
| | IDF-11774 Basic information |
| Product Name: | IDF-11774 | | Synonyms: | IDF-11774;Ethanone, 1-(4-methyl-1-piperazinyl)-2-(4-tricyclo[3.3.1.13,7]dec-1-ylphenoxy)-;IDF 11774;IDF11774;CS-2820;IDF 11774,inhibit,HIF-PH,IDF-11774,Hypoxia-inducible factors,HIFs,IDF11774,Inhibitor,HIF/HIF Prolyl-Hydroxylase;2-[4-(1-adamantyl)phenoxy]-1-(4-methylpiperazin-1-yl)ethanone;2-(4-(Adamantan-1-yl)phenoxy)-1-(4-methylpiperazin-1-yl)ethanone | | CAS: | 1429054-28-3 | | MF: | C23H32N2O2 | | MW: | 368.51 | | EINECS: | | | Product Categories: | | | Mol File: | 1429054-28-3.mol |  |
| | IDF-11774 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 60 mg/mL (162.82 mM) | | form | Solid | | color | White to off-white |
| | IDF-11774 Usage And Synthesis |
| Uses | IDF-11774, is a novel hypoxia-inducible factor (HIF)-1 inhibitor with an IC50 of 3.65 μM in cancer cell line. It has shown to reduce capillary network formation on Matrigel, when human umbilical vascular endothelial cells (HUVECs) were treated with IDF-11774. |
| | IDF-11774 Preparation Products And Raw materials |
|